This application is the U.S. National Stage of PCT App. Ser. No. PCT/US2015/019519, filed Mar. 9, 2015.
The present inventions relate generally to hearing devices and, for example, hearing devices that are worn entirely in the ear canal for extended periods without daily insertion and removal.
Referring to the coronal view illustrated in
Extended wear hearing devices are configured to be worn continuously, from several weeks to several months, inside the ear canal. Some extended wear hearing devices are configured to rest entirely within the bony region and, in some instances, within 4 mm of the tympanic membrane. Examples of extended wear hearing devices are disclosed in U.S. Patent Pub. No. 2009/0074220, U.S. Pat. No. 7,664,282 and U.S. Pat. No. 8,682,016, each of which is incorporated herein by reference. Such hearing devices frequently include one or more seal retainers (or “seals”) that suspend and retain the hearing device within the ear canal and also suppress sound transmission and feedback which can occur when there is acoustic leakage between the receiver and microphone. The seals are frequently formed from a highly porous and highly compliant foam material (e.g., hydrophilic polyurethane foam), which conforms to the ear canal geometry by deflection and compression, using a net-shape molding process. The seals tend to be very small, with outer diameters of around 0.5 inch, and very thin, with wall thicknesses of around 0.02 to 0.03 inch.
The present inventors have determined that hearing devices which are configured to be placed deep in the ear canal are susceptible to improvement. For example, there are a variety of important, and sometimes conflicting, functional goals associated with the seals. Although the friction between the seals and the ear canal must be sufficient to prevent lateral migration of the hearing device, the seals must be compliant enough to conform to the ear canal, and the local pressure exerted on the ear canal wall should be less than the venous capillary return pressure of the epithelial tissue layer of the canal wall (i.e., less than about 12 mmHg). The seals must be durable in that there is no more than minimal degradation or change of structural integrity in response to prolonged contact with sweat, ear wax and soapy water. The seals should also be skin biocompatible. Acoustically, the seals should provide acoustic attenuation in order to prevent feedback (e.g., >40 dB between 200 Hz and 6 kHz). The seals should permit venting that allows pressure equalization between the ambient environment and the closed volume near the tympanic membrane, and have a vapor transmission rate sufficient to prevent moisture accumulation in the closed volume (e.g., MVTR>0.05 mg/h/mm2 at 37° C.). The present inventors have further determined that, given their very thin wall thicknesses, it is difficult to reliably manufacture seals that achieve these goals using net-shape molding and other currently available manufacturing techniques for manufacturing foam objects. In particular, reliably achieving good acoustic attenuation often occurs at the expense of compliance and comfort.
A hearing device in accordance with at least one of the present inventions includes a hearing device core defining an exterior surface and a seal, including a shell wall, mounted on the hearing device core with the first end of the shell wall secured to the hearing device core and the second end located in spaced relation to the hearing device core. A cavity, which has an opening located at the shell wall second end, is defined between the hearing device core exterior surface and the shell wall interior surface. A volume of viscous medium may be located within the cavity between the hearing device core exterior surface and the shell wall interior surface.
There are a variety of advantages associated with such a hearing device. By way of example, but not limitation, the viscous medium augments the sound attenuation associated with the seal and promotes vapor transmission without substantially increasing the pressure on the ear canal wall associated with the seal or interfering with pressure equalization.
The above described and many other features of the present inventions will become apparent as the inventions become better understood by reference to the following detailed description when considered in conjunction with the accompanying drawings.
Detailed descriptions of the exemplary embodiments will be made with reference to the accompanying drawings.
The following is a detailed description of the best presently known modes of carrying out the inventions. This description is not to be taken in a limiting sense, but is made merely for the purpose of illustrating the general principles of the inventions. Referring to
As illustrated in
Referring first to
Turning to
With respect to materials, the seals 104 and 106 may be formed from compliant material configured to conform to the shape of the ear canal. Suitable materials include elastomeric foams having compliance properties (and dimensions) configured to conform to the shape of the intended portion of the ear canal (e.g., the bony portion) and exert a spring force on the ear canal so as to hold the hearing assistance device 100 in place in the ear canal. Exemplary foams, both open cell and closed cell, include but are not limited to foams formed from polyurethanes, silicones, polyethylenes, fluoropolymers and copolymers thereof. Hydrophilic polyurethane foam is one specific example. In at least some embodiments, all or a portion of the seals can comprise a hydrophobic material including a hydrophobic layer or coating that is also permeable to water vapor transmission. Examples of such materials include, but are not limited to, silicones and fluoropolymers such as expanded polytetrafluoroethylene (PTFE).
Turning to the viscous medium 108, the viscous medium employed will preferably enhance sound attenuation without significantly increasing the stiffness of the associated seal (e.g., seal 104). Exemplary viscous media include, but are not limited to, purely viscous media such as glycerol, petroleum jelly and wax, viscoelastic media such as a rubber, and gelled viscous media (or “gel”). The properties of the gels and other viscous media, which are preferably hygroscopic, provide sufficient moisture transport to promote ear health.
The viscous medium 108 in the illustrated embodiment is a gel. Various examples of gelled viscous media, and the benefits associated therewith, are provided below. The gels may have relatively weak cross-linking between the polymer chains. This results in a structural coherence that is sufficient to prevent the gel from flowing out of the cavity 158, regardless of the orientation of the hearing assistance device, or diffusing into the seal foam during storage at room temperature or usage at body temperature, and also results in a modulus that is low enough to preclude substantial reductions in the compliance of the seal that would increase pressure on the ear canal wall. During manufacture, the hearing assistance device 100 may be oriented such that the medial end faces downwardly and the gel may be injected into the cavity 158 in a liquid state with a syringe or other suitable dispenser. The liquid will be allowed to cure and form the gel 108 that occupies most (or all) of the cavity 158 and is mechanically interlocked with the foam of the seal 104. Because the cavity 158 has an opening 160, and because the gel (or other viscous medium in other embodiments) is not located with a bag, balloon, bladder or other enclosed structure, the gel is free to flow out of the cavity when the seal 104 is compressed. The same manufacturing technique may be employed in conjunction with purely viscous and viscoelastic media.
When the hearing assistance device 100 is inserted into the ear canal 10, it will transition from the uncompressed state (
As noted above, exemplary viscous media include purely viscous media, viscoelastic media, and gels. A purely viscous medium will flow and redistribute as the seal conforms to the canal, thereby occupying space and enhancing overall sound attenuation. The purely viscous medium with not add to the restoring force of the seal 104 and the only pressure against the ear canal walls will only be that provided by the elastic spring force of the compressed seal. The present inventors have determined although that purely viscous media may not flow evenly through the opening 160 and out of the cavity 158 when the seal 104 is pressed into the ear canal and compressed, a purely viscous medium may be useful in some implementations because it does not add to the restoring force of the seal and the pressure exerted onto the ear canal wall. A purely viscous medium may also flow out of the cavity 158 (depending on the orientation of the hearing assistance device) or diffuse into the foam that forms the seal during storage. A viscoelastic medium, on the other hand, will provide a restoring force as it is deflected, which will add to the restoring force of the seals as well as providing sound attenuation. Care must be taken to insure that the total restoring force is less than the venous capillary return pressure of the epithelial tissue layer. Nevertheless, it should be emphasized that, like the purely viscous media, viscoelastic media may be employed as desired or required by particular implementations.
With respect to gels, one exemplary gel is clay/glycerine gel. Clays such as, for example, bentonite, smectite, montmorillonite, hectorite, and synthetic silicate, can swell significantly in aqueous solution or organic polar liquids due to intercalation of liquids into the silicate layers, thereby thickening the solutions into a non-flowable gel. For example, a glycerine gel made with 2.25% clay will remain a non-flowable gel at temperatures up to 100° C. The deflection force associated with the seal 104 and gel 108 will only be about 5-6% greater than that associated with an otherwise identical seal 104 alone. The gel may be produced by the following process: (1) disperse the clay into water to form a water/clay gel, (2) add glycerine to the water/clay gel to form a glycerine/water/clay mixture, and (3) evaporate the water to produce the glycerine/clay gel. The glycerine/clay gel can be placed into a syringe (in liquid form) and dispensed in the manner described above.
Another exemplary gel is Carbopol®/glycerine gel. Carbopol® (polyacrylic acid) leads to a water based hydrogel with trometamol (tris) and propylene glycol. Its viscosity is pH dependent, and the viscosity decreases when pH decreases. Directly mixing Carbopol® into glycerine, followed by neutralization, significantly increases the viscosity of the glycerine. While the viscosity without Carbopol® is about 1150 cp, the viscosity increases to about 26500 cp with 0.4% Carbopol®. Higher amounts of Carbopol® can be dispersed into glycerine for higher viscosities. The gel may be produced by the following process: (1) mix Carbopol® in water, (2) add glycerine, (3) neutralize, and (4) remove the water to produce the Carbopol®/glycerine gel. The Carbopol®/glycerine gel can be placed into a syringe (in liquid form) and dispensed in the manner described above.
Still another exemplary gel is agar-glycerine gel with an agar concentration of about 1.6% to 1.7%. Here, the temperature of the mixture should be about 95° C. to 100° C. (and not yet gelled) when dispensed into the seal in the manner described above. The mixture will begin to gel when it cools to about 40° C.
Yet another exemplary gel is polyvinyl alcohol gel, which is a water based hydrogel that may involve the use of a cross-linking agent such as borane (trihydridoboron).
It should be noted here that the viscous medium 108 may be injected or otherwise dispensed into the cavity 158, which is located between the exterior surface of the hearing device core 102 and the shell wall interior surface 150, at any appropriate time. For example, the viscous medium 108 may be dispensed into the cavity 158 during the hearing device manufacturing process (prior to packaging and shipping), or at the point of sale, or at the time of fitting. In the case of fitting, the viscous medium 108 is provided separately to the hearing healthcare professional (e.g., in a syringe with a dispensing needle) so that the viscous medium 108 can be dispensed into the cavity 158 just moments prior to fitting or inserting the hearing device into the ear canal. A similar process may be employed for those users who are capable of dispensing the viscous medium 108 into the cavity 158 themselves at the time of insertion.
The size and geometry of the ear canal varies from one person to another and, accordingly, so does the size and geometry of the hearing device 100. Variation in the size and geometry of the hearing device 100 may be accomplished by way of variations in the size and geometry of the medial seal 104 and the lateral seal 106. The volume of the cavity 158 between the exterior surface of the hearing device core 102 and the shell wall interior surface 150 will vary from one hearing device to another due to the variations in the size of the medial seal 104, as will the volume of the viscous medium 108 within the cavity 158. The geometry of the ear canal also plays a role in the volume of the cavity 158 when the hearing device is located within the bony region. In those instances where the medium diameter of the hearing device core is about 4 mm, the volume of the viscous medium 108 may range from 5 μl for a medial seal 104 that is appropriate for narrow ear canal (canal medium diameter of 5 mm) to 100 μl for a medial seal 104 that is appropriate for a large ear canal (canal medium diameter of 10 mm).
If the quantity of viscous medium 108 that is dispensed into the cavity 158 is too low, then the acoustic attenuation may not meet the desired level. If, on the other hand, the quantity is too high, the viscous medium 108 may leak out of the cavity 158 in an uncontrolled manner and, possibly, block the microphone contamination guard 140 or cause other undesirable effects. As such, in at least some implementations, the hearing assistance device 100 may be configured to facilitate receipt of the correct amount of viscous medium 108. For example, a mark (not shown) that indicates when maximum volume has been dispensed into the cavity 158 may be located on the interior surface 150 of the medial seal 104. The mark can be added the seal after it is formed, or can be an integrated structure (e.g., a groove or protrusion) that is formed during manufacture of the seal. The mark can extend around the entire circumference of seal inner surface 150 (at the location that corresponds to the desired volume) or can be located at one or more discrete locations on the inner surface. Such a mark is useful, whether the viscous material is dispensed during manufacturing, or by the audiologist, or by the user, because exact dosing of a viscous medium can be challenging.
Certain aspects of the inner surface 150 of the medial seal 104 and/or the outer surface of the core 102 may be initially manufactured, or modified prior to the addition of the viscous medium 108, so as to improve the interaction with the viscous medium. For example, the inner surface 150 of the medial seal 104 and/or the outer surface of the core 102 may be manufactured or modified so as to adhere to a particular viscous medium 108. Such surface aspects include, but are not limited to, roughness, porosity, hydrophobicity and hydrophilicity, as well as any and all combinations thereof.
Although the inventions disclosed herein have been described in terms of the preferred embodiments above, numerous modifications and/or additions to the above-described preferred embodiments would be readily apparent to one skilled in the art. By way of example, but not limitation, the inventions include any combination of the elements from the various species and embodiments disclosed in the specification that are not already described. It is intended that the scope of the present inventions extend to all such modifications and/or additions and that the scope of the present inventions is limited solely by the claims set forth below.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2015/019519 | 3/9/2015 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2016/144319 | 9/15/2016 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
20060291682 | Urso | Dec 2006 | A1 |
20060291683 | Urso | Dec 2006 | A1 |
20070121980 | Menzl | May 2007 | A1 |
20080144871 | Purcell et al. | Jun 2008 | A1 |
20090320859 | Purcell | Dec 2009 | A1 |
20130130097 | Wenzel | May 2013 | A1 |
Number | Date | Country |
---|---|---|
2384021 | Jul 2015 | EP |
WO 0042817 | Jul 2000 | WO |
WO 2014040649 | Mar 2014 | WO |
Entry |
---|
PCT Search Report and Written Opinion dated Sep. 23, 2015 for PCT App. Ser. No. PCT/US2015/019519. |
Number | Date | Country | |
---|---|---|---|
20180041852 A1 | Feb 2018 | US |